Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT04057196
Official study title

Self-System Therapy for Older Adults With Lung Cancer

Study summary

The purpose of this study to use Self-system therapy (SST), to treat depression and lung-cancer-related distress in older adults (65 years and older).

Ask AI to explain this study
Start here

Key things to know

Main goalSupportive Care

This describes the study’s primary purpose.

What is being studiedSelf-System Therapy for Older Adults with Advanced Lung Cancer (SST-LC)

The study team can explain what participation involves.

Who it may be forLocally advanced · Metastatic or stage IV

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Aug 3, 2022 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Duke University

Study sponsor

01
Study overview

What this study is about

Purpose
Supportive Care
Study type
Interventional
Phase
Not applicable
Sponsor
Duke University
Interventions being studied
Behavioral: Self-System Therapy for Older Adults with Advanced Lung Cancer (SST-LC)
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Disease setting
Locally advanced→Metastatic or stage IV→
Treatment approach
Supportive or behavioral care→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Age ≥ 65 years
  • English-speaking
  • The patient has a diagnosis of late-stage (III-IV) lung cancer and is living at her/his home.
Reasons someone may not be able to joinExclusion criteria
  • Unable to provide informed consent
  • Visual or hearing impairments that preclude participation
  • Serious mental illness

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Duke UniversityDurham, North Carolina

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 3, 2022. Always confirm current availability with the study team.

View original record ↗